[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344895-105":59,"doc-detail-344895-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","biomimetic-nanoparticles-for-targeted-and-efficient-cancer-therapy-progress-challengesand-perspectives","Biomimetic Nanoparticles for Targeted and Efficient Cancer Therapy: Progress, Challengesand Perspectives","","Cancer remains a major cause of global mortality, with more than 200 identified forms and projections of a 25% increase in fatalities by 2030. While early diagnosis and multimodal treatment are critical, current therapies face limitations including off-target drug distribution, toxicity, and constrained efficacy. Biomimetic nanoparticles have emerged as nanocarriers capable of site-specific release, improved biocompatibility, longer circulation, and reduced immune responses, especially membrane-coated systems with tumor-relevant functionalization. This review summarizes recent advances and discusses production scale-up, structural integrity during drug loading, clinical and biosafety considerations, regulatory needs, and translational challenges.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/biomimetic-nanoparticles-for-targeted-and-efficient-cancer-therapy-progress-challengesand-perspectives/344895/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/biomimetic-nanoparticles-for-targeted-and-efficient-cancer-therapy-progress-challengesand-perspectives/344895.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are early diagnosis and treatment critical in cancer?","Question",{"text":113,"@type":114},"Early diagnosis enables more effective intervention. Current treatments are often challenged by limitations such as non-targeted distribution, toxicity, and limited efficacy, making timely and improved strategies essential.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What advantages do biomimetic nanoparticles offer for cancer therapy?",{"text":118,"@type":114},"Biomimetic nanoparticles can provide site-specific drug release, enhance biocompatibility, prolong circulation time, and reduce immune responses, which together can improve therapeutic outcomes.",{"name":120,"@type":111,"acceptedAnswer":121},"Which cell membrane sources are highlighted for coated biomimetic nanoparticles?",{"text":122,"@type":114},"The review highlights membrane-coated nanoparticles derived from red blood cells, cancer cells, platelet cells, macrophages, exosomes, hybrid cells, and protein/serum albumin for cancer therapy.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},344895,1790145950,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":36,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","International Journal of Nanomedicine  \nOpen Access Full Text Article REVIEW  \nBiomimetic Nanoparticles for Targeted and Efficient Cancer Therapy: Progress, Challengesand Perspectives  \nTarun Kumar 1 , *, Nitin Thakur 1 , *, Simran 1 , Amit Kumar Prusti 1 , Raj Kumar 2 , Ajeet Kaushik 3 , Arun Kumar 1  \n1Department of Pharmacy, School of Health Sciences, Central University of South Bihar, Gaya, India; 2School of Health Sciences and Technology, UPES University, Dehradun, Uttarakhand, India; 3NanoBioTech Laboratory, Department of Chemistry, Florida Polytechnic University, Lakeland, FL, USA  \n*These authors contributed equally to this work  \nCorrespondence: Arun Kumar, Department of Pharmacy, School of Health Sciences, Central University of South Bihar, SH-7, Gaya- Panchanpur Road, Village- Karhara, Post- Fatehpur, P.S-Tekari, Gaya, Bihar, 824236, India,  \nEmail [arundhiman431@gmail.com](arundhiman431@gmail.com); Ajeet Kaushik, NanoBioTech Laboratory, Department of Chemistry, Florida Polytechnic University, Lakeland, FL, 33805, USA, Email [ajeet.npl@gmail.com](ajeet.npl@gmail.com)  \n| Abstract: Cancer remains a prominent cause of global mortality, with over 200 identified forms, and is projected to have a 25% increase in fatalities by 2030. Early diagnosis and treatment are crucial, but current therapy, which includes surgery, chemotherapy, immunotherapy, hormonal therapy, targeted therapy, and radiotherapy, faces challenges such as non-targeted drug distribution, toxicity, and limited efficacy. In recent years, biomimetic nanoparticles have emerged as a promising nanocarrier with great potential that enables site-specific drug release, improves biocompatibility, prolongs circulation time, and minimizes immune responses. Among various biomimetic nanoparticles, nanoparticles coated with cell membranes, such as those from cancer cells, immune cells, and stem cells, have been shown to have great potential for cancer treatment. The cell membrane-coated nanoparticles, further functionalized with tumor-specific ligands, demonstrated potential in improving half-life, drug specificity, and overall therapeutic efficacy. In this comprehensive article, we have reviewed recent advances in cell membrane-coated biomimetic nanoparticle systems for cancer therapy. We discussed the biomimetic nanoparticles coated with membranes of red blood cells, cancer cells, platelet cells, macrophages, exosomes, hybrid cells, and protein/serum albumin for cancer therapy. This review also highlights challenges associated with large-scale production, maintaining structural integrity during drug loading, clinical and biosafety aspects, regulatory requirements, and the clinical translation of the cell membrane-coated biomimetic nanoparticle systems.\u003Cbr>Keywords: targeted delivery, cell membrane-coated nanoparticles, biomimetic nanoparticles, cancer therapy |\n| --- |\n| Introduction\u003Cbr>Cancer is a formidable worldwide health concern and remains a substantial contributor to worldwide mortality. Cancer can be defined as the uncontrolled division or growth of cells that can easily evade and destroy their surroundings and can also spread to other parts of the body. The grim statistics on cancer-related deaths underscore its profound impact on individuals and societies. According to the 2020 report from the World Health Organization’s Global Cancer Observatory, malignancies hold the unenviable position of being the foremost cause of global mortality. Carcinoma cells, responsible for this devastating disease, exhibit marked morphological abnormalities, including pleomorphism, loss of cellular polarity, and anaplasia, characteristics that enable their aggressive spread to distant anatomical sites.1 More than 200 distinct cancer forms have been identified worldwide to date. The WHO projects a worrisome 25% increase in cancer-related fatalities from 2020 to 2030, underscoring the pressing need for effective prevention and treatment |\n\n[https://doi.org/10.2147/IJN.S579622](h","cbCaiun9xs2JfIUq","https://ap.wps.com/l/cbCaiun9xs2JfIUq","pdf",20216195,"English","# Introduction\n## Cancer burden and current treatment challenges\n## Promise of biomimetic, membrane-coated nanoparticles\n# Abstract overview\n## Progress and potential mechanisms\n## Key challenges and translation considerations","[{\"question\":\"Why are early diagnosis and treatment critical in cancer?\",\"answer\":\"Early diagnosis enables more effective intervention. Current treatments are often challenged by limitations such as non-targeted distribution, toxicity, and limited efficacy, making timely and improved strategies essential.\"},{\"question\":\"What advantages do biomimetic nanoparticles offer for cancer therapy?\",\"answer\":\"Biomimetic nanoparticles can provide site-specific drug release, enhance biocompatibility, prolong circulation time, and reduce immune responses, which together can improve therapeutic outcomes.\"},{\"question\":\"Which cell membrane sources are highlighted for coated biomimetic nanoparticles?\",\"answer\":\"The review highlights membrane-coated nanoparticles derived from red blood cells, cancer cells, platelet cells, macrophages, exosomes, hybrid cells, and protein/serum albumin for cancer therapy.\"}]","Biomimetic Nanoparticles for Targeted and Efficient Cancer Therapy: Progress, Challengesand Perspectives | PDF",1790055668,101,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f08e3ea4241002bcdc7f11f1f97c2e30.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/754df7d4e66d507011e73ecff73ef172.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f21ac9e3782492d7644f834cfa118c5f.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a324e9bfa2631bb50fa28f460b031170.webp",980,1268]